Clinical Trial Update: SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial called SPENDD is evaluating quantitative sensory testing and analgesic response in painful peripheral neuropathies and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Diabetic Peripheral Neuropathy
• Idiopathic Peripheral Neuropathy
• Peripheral Neuropathy

Snippet

Sponsor: University of Rochester | Conditions: Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN) | Phase 2 | Status: RECRUITING